Verrica Pharmaceuticals Inc (VRCA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Verrica Pharmaceuticals Inc   (NASDAQ: VRCA)

Verrica Pharmaceuticals Inc

Officers & Directors


Lawrence Eichenfield
Director

Diem Nguyen
Director

Craig Ballaron
Director

Mark Prygocki
Director

Sean Stalfort
Director

Ted White
President, Chief Executive Officer and Director (Principal Executive Officer)

Paul B. Manning
Chairman of the Board of Directors

P. Terence Kohler, Jr.
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)


We have served as the Company s auditor since,

Verrica Pharmaceuticals Inc currently has 76 employees.

  News about Verrica Pharmaceuticals Inc Key Personnel

Verrica Pharmaceuticals Advances Clinical Development of YCANTH for Common Warts Following Positive FDA Meeting


by
In a recent announcement, Verrica Pharmaceuticals Inc. revealed that it has received the minutes from its Type C meeting with the U.S. Food and Drug Administration (FDA) regarding the clinical development of YCANTH for the treatment of common warts. This meeting was held on November 6, 2023, with the aim of discussing the Phase 3 clinical development plan for the medication.
Verrica Pharmaceuticals, a dermatology therapeutics company specializing in the development of medical interventions for skin diseases, expressed its satisfaction with the outcome of the meeting. The company believes that the Type C meeting successfully achieved its primary objective of obtaining advice and agreement fro...






VRCA Management Effectiveness VRCA Revenue per Employee VRCA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.